|
Types
|
CAR19/22 (N = 84)
|
CAR-BCMA (N = 16)
|
HSCT + CAR-19/22 (N = 9)
|
Total (N = 109)
|
|---|
|
Any infection†
|
14 (16.7)
|
3 (18.8)
|
2 (22.2)
|
19 (17.4)
|
|
Infection grading
|
|
Grade 1–2
|
3 (3.6)
|
0 (0.0)
|
0 (0.0)
|
3 (2.8)
|
|
Grade 3
|
2 (2.4)
|
1 (6.3)
|
2 (22.2)
|
5 (4.6)
|
|
Grade 4–5
|
9 (10.7)
|
2 (12.5)
|
0 (0.0)
|
11 (10.1)
|
|
Infection microorganisms
|
|
Bacteria
|
10 (11.9)
|
3 (18.8)
|
1 (11.1)
|
14 (12.8)
|
|
Fungi
|
1 (1.2)
|
0 (0.0)
|
1 (11.1)
|
2 (1.8)
|
|
Virus
|
3 (3.6)
|
0 (0.0)
|
0 (0.0)
|
3 (2.8)
|
|
Infection site
|
|
Lung
|
1 (1.2)
|
2 (12.5)
|
2 (22.2)
|
5 (2.8)
|
|
Bloodstream
|
11 (13.1)
|
1 (6.3)
|
0 (0.0)
|
11 (10.1)
|
|
Others
|
2 (2.4)
|
0 (0.0)
|
0 (0.0)
|
2 (1.8)
|
- Data are presented as number of patients (percentage in each therapeutic group)
